TrialBMC cancer2007

Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas.

Victor A Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.